09262018Headline:

Aseptic Sampling Market: Drivers, Challenges, Opportunities

The global aseptic sampling market is projected to reach USD 1,247.0 million by 2023 from USD 662.1 million in 2018, at a CAGR of 13.5%.

The growth of the market can be attributed to the increasing demand for biopharmaceuticals, stringent government regulations to ensure drug safety, and increasing adoption of single-use aseptic sampling products in the bioproduction processes.

In this report, the global aseptic sampling market is segmented on the basis of type, technique, application, end user, and region. On the basis of type, the aseptic sampling market is categorized into manual aseptic sampling and automated aseptic sampling. In 2018, the manual aseptic sampling segment is expected to account for the largest share of the aseptic sampling market. Manual aseptic sampling has traditionally been used in pharmaceutical and biotechnology manufacturing. The introduction of single-use systems has helped drug manufacturers mitigate cross-contamination and cost issues. Moreover, manufacturers are reluctant to shift to automatic sampling, citing high costs and the need to train staff to handle the latter.

On the basis of technique, the aseptic sampling market is segmented into off-line, at-line, and on-line. In 2018, the off-line segment is expected to account for the largest share in the aseptic sampling market Off-line sample collection is a traditional and widely used method of collecting samples aseptically, which leads to the largest share of the segment.

On the basis of end user, the aseptic sampling market is segmented into pharmaceutical and biotechnology manufacturers, CROs and CMOs, R&D departments, and other end users. The pharmaceutical and biotechnology manufacturers segment is expected to account for the largest market share in 2018. The large share of this segment can be attributed to the increasing adoption of aseptic sampling in existing manufacturing facilities owing to their low capital cost and easy implementation.

In 2018, in terms of value, Europe is expected to account for the largest share of the global aseptic sampling market. Governments in several European countries are supporting pharmaceutical companies to launch new biologic therapies that offer superior efficacy than traditional drugs. This in turn is increasing the number of R&D activities in the region. Aseptic sampling products help manufacturers to eliminate the risk of contamination which leads to growth of the market in Europe.

On the other hand, many biopharmaceutical processes often require high temperatures during their operation, which results in the generation of unnecessary and unknown chemicals that can contaminate the end product. This is a major factor restricting the use of single-use bioprocessing systems. This issue extends to single-use aseptic sampling products as well, as they are made of processed plastic materials and face the problem of contamination from the container due to leachables. Thus, issues related to leachables and extractables of single-use products is the factor restraining market growth.

Get Free Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=9034729

The key players in the aseptic sampling market include Sartorius Stedim Biotech (France), Merck Millipore (Germany), Danaher (US), and Thermo Fisher Scientific (US). These players focus on inorganic strategies such as acquisitions, agreements, and collaborations.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com

What Next?

Related Articles